Yue-Liang Yao

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 14, 2022
Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation-driven medulloblastoma.

Yue-Liang Yao, Yan-Xia Wang, Fei-Cheng Yang

Pageof 1

Frequent Collaborators